Testoluten Testes Bioregulator Protocol - Peptide Dosages

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Testoluten (Testes Bioregulator) Dosage Protocol

A natural peptide complex extracted from animal testicular tissue, sold as an oral "Cytomax" bioregulator for male reproductive support. The studied testes science belongs to the preparation testilin and the synthetic analog Testagen — not to this specific extract, whose composition is proprietary. Russian-registered as a parapharmaceutical; not a drug and not FDA-approved.

A natural peptide complex extracted from animal testicular tissue ("Cytomax" A-13), sold as oral capsules in the Russian peptide-bioregulator tradition. It is a proprietary extract, distinct from its studied relatives: the testes preparation testilin and the synthetic analog Testagen.

An oral capsule, commonly 20 mg, taken as a course: typically 1-2 capsules daily for 10-30 days, repeated 2-3 times per year. No reconstitution, no injection. This is the conventional bioregulator schedule, not a validated therapeutic dose.

The testes data belong to the preparation testilin: in an animal infertility model, testilin (with the prostate preparation prostatilen) stimulated spermatogenesis and androgenic function. Testoluten itself is a proprietary oral extract with Russian-language, largely uncontrolled data. Not a drug, not FDA-approved, and no controlled human evidence for testosterone or fertility benefit.

Quickstart Highlights

Testoluten (product code A-13) is a natural peptide complex extracted from the testicular tissue of young animals, sold in oral capsules as the testes member of the Russian “Cytomax” peptide bioregulators[1][3]. It is marketed for male reproductive and testosterone “support” and fertility.

The honest framing is the family’s: the studied testes science belongs to Testoluten’s defined relatives — the testes peptide preparation testilin and the synthetic analog Testagen — not to this specific extract[2]. Testoluten itself is a natural extract of proprietary composition with Russian-language, largely uncontrolled data, and it is not a drug and not FDA-approved. This page is an educational reference, not medical advice; infertility and low testosterone need proper medical evaluation.

Supplies Needed

Testoluten is an oral capsule, so there is no reconstitution kit and no injection equipment. What matters is a genuine, well-stored product from a trusted source; as a natural testicular-tissue extract, identity and storage matter more than for a defined synthetic peptide.

Protocol Overview

Testoluten is the testes member of the Cytomax family of natural peptide extracts, sold as an oral bioregulator for male reproductive and testosterone “support” in the Khavinson tradition[1][3]. Its rationale is the peptide theory of ageing: short, tissue-specific peptides are proposed to help normalise function in the tissue they derive from — here, the testes.

The overview’s honest core is the gap between the family’s science and this product. The concrete testes data belong to the preparation testilin: in an animal infertility model it stimulated spermatogenesis and androgenic function and helped correct androgen-estrogen balance[2]. Testoluten is the natural oral extract, of proprietary composition, with Russian-language and largely uncontrolled data — a parapharmaceutical, not an approved drug, with no controlled human evidence for a testosterone or fertility benefit.

Dosing Protocol

Because Testoluten is an oral capsule, the “protocol” below is a course schedule, not a reconstitution ladder. These figures are the conventional bioregulator regimen, not a clinically validated dose for this extract.

Capsule

20 mg testicular peptide complex

Oral; no reconstitution

Course

1–2 caps daily × 10–30 days

Often before a meal

Repeat

2–3 courses per year

Conventional “pulse” pattern

What is studied[2]

Preparation testilin (animal model)

Not the extract, not human

Why Testoluten draws research interest

These are the directions researchers and the peptide community most often explore Testoluten for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

The fertility data are testilin’s, and they are in animals

The concrete testes science is for the preparation testilin — in an animal infertility model it stimulated spermatogenesis and androgenic function, paired with the prostate preparation prostatilen. Testoluten is the oral natural extract sold as a Cytomax capsule; it is a relative of testilin and the synthetic analog Testagen, not the tested preparation, and the data are animal, not human.

A testicular-tissue extract has no fixed formula

Testoluten is purified from animal testicular tissue, so its contents are defined by manufacturing rather than a chemical structure. Batch consistency depends on the maker, a grey-market copy has no guarantee of identity, and being animal-derived it carries the general considerations of tissue-sourced products.

Low testosterone and infertility need a workup, not a capsule

Male infertility and low testosterone have identifiable, often treatable causes that require proper evaluation (hormone testing, semen analysis, and looking for underlying conditions). The evidence for Testoluten is Russian-only and uncontrolled, and testilin’s data are animal. Substituting a proprietary testicular extract for a medical workup can delay effective treatment.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

An oral capsule, commonly 20 mg of testicular peptide complex. No vial, no reconstitution, no needle.

Typically 1–2 capsules daily for a 10–30 day course, repeated 2–3 times per year[3]. A conventional bioregulator schedule, not an FDA-cleared regimen.

The testes preparation testilin stimulated spermatogenesis and androgens in an animal model[2]; Testoluten is the natural extract, not that studied preparation.

Bioregulator — Russian-only, largely uncontrolled. Testilin data are animal and older; the extract’s own claims are unconfirmed by Western trials. Not FDA-approved.

Oral Dosing Guide

Testoluten is dosed like a supplement course: oral capsules daily for a set number of days, then a break, repeated a few times a year[3]. What follows is that convention, framed honestly against the fact that the concrete testes data are animal data for testilin and the analog Testagen, not this extract[2].

Standard / Gradual Approach

The conventional bioregulator regimen is 1–2 capsules (commonly 20 mg each) once daily for a 10–30 day course, usually before a meal, with courses repeated 2–3 times per year[3]. This short-course, long-gap “pulse” pattern is shared across the Cytomax line and is a convention, not a dose optimised for Testoluten in a controlled trial.

The concrete data used the testes preparation testilin in an animal infertility model, not an oral human regimen[2]. There is no established human dose for Testoluten and no controlled human trial to anchor to; the capsule schedule is a bioregulator convention, not a fertility protocol.

Because there is no validated dose-response for the extract, more is not better and stacking organ bioregulators has no controlled support. Anyone following the numbers is copying a bioregulator schedule for a proprietary natural extract whose own effects have not been shown in controlled human trials.

Storage Instructions

Keep Testoluten capsules in a cool, dry place, sealed and out of light, per the supplier’s guidance. As a natural peptide extract it is more sensitive to poor storage than a simple synthetic compound.

Because it is an animal-tissue extract, source and handling matter: a genuine, properly stored product is very different from an unverified grey-market copy with no guarantee of identity or purity.

Important Notes

These are the points most often lost when Testoluten is marketed internationally as a testosterone or fertility “peptide.”

▪The data belong to testilin, and they are animal: the concrete evidence is an animal model of the testes preparation testilin, not a human trial of Testoluten[2]. Treating that as human proof for the extract is the core error to avoid.

▪It is a natural extract, not a defined molecule: the capsule contains a proprietary testicular peptide complex, so composition is set by manufacturing and grey-market copies have no guarantee of identity[3].

▪No controlled human testosterone/fertility data: there are no Western controlled trials showing Testoluten raises testosterone or improves fertility in men; the supportive literature is Russian and largely uncontrolled[3].

▪It is a parapharmaceutical, not a drug: Testoluten is not FDA-approved and is sold as a supplement. It must not replace a proper workup for infertility or low testosterone.

▪Animal-derived: being purified from animal testicular tissue, it carries the general considerations of tissue-sourced biologicals; quality and sourcing matter accordingly.

How This Works

The proposed mechanism is the peptide theory of ageing applied to the testes: short, tissue-specific peptides are proposed to support testicular function — spermatogenesis and androgen production — and counter age-related decline[1].

The concrete data come from the testes preparation testilin. In an animal model of infertility, testilin (with the prostate preparation prostatilen) stimulated spermatogenesis and androgenic function and helped correct androgen-estrogen balance[2]. The proposed target is the seminiferous epithelium and Leydig-cell (androgen-producing) function.

The honest limit is that this is animal testilin biology, and it does not establish that the oral natural extract Testoluten raises testosterone or improves fertility in humans. The mechanism is a plausible, long-standing hypothesis with limited animal support for the preparation — not controlled human proof for this capsule[3].

Lifestyle Factors

For testosterone and fertility, the evidence-based path is medical and behavioural: proper evaluation of low testosterone or infertility, plus habits that genuinely help — healthy weight, resistance exercise, adequate sleep, limiting alcohol, and managing conditions like sleep apnoea and metabolic disease. These do far more than an oral peptide extract.

The honest “daily habits” note is a redirection: a real workup and proven lifestyle measures carry evidence that a Russian-tradition bioregulator does not, and they avoid delaying treatment of a correctable cause.

Potential Benefits & Side Effects

Evidence tier: bioregulator — animal data for the preparation testilin, and no controlled human evidence for the extract. The “effects” below are largely testilin (animal) findings; the “considerations” are the honest counterweight.

Reported Effects

▪Spermatogenesis — animal data: the testes preparation testilin stimulated spermatogenesis in an animal infertility model[2].

▪Androgen function — animal data: testilin stimulated androgenic function and helped correct androgen-estrogen balance in the same model[2].

▪Tissue-specific peptide concept: the bioregulator theory proposes testes-specific peptides support testicular function[1].

▪What is not established: that the oral natural extract Testoluten raises testosterone or improves fertility in humans. There are no Western controlled trials, and the testilin data are animal[3].

Common Side Effects

▪Reported tolerability is good — from uncontrolled studies: the bioregulators are described as well tolerated, but open-label Russian data are poor at detecting and attributing adverse effects[3].

▪Natural-extract uncertainty: composition is proprietary and animal-derived, so the true content and purity of any product — especially a grey-market copy — are not guaranteed.

▪Missed-diagnosis risk: using a testicular extract for infertility or low testosterone can delay identifying a treatable cause — the most important safety point here.

▪Western safety data are absent: without controlled trials outside Russia, the international side-effect profile of Testoluten is not independently characterised.

Oral Administration

Testoluten is taken by mouth as a capsule — there is no mixing, no needle and no injection technique. The steps below keep an oral bioregulator course simple and consistent; they are educational, not medical instructions.

Before You Dose

▪Confirm the product and course: check that you have a genuine testes bioregulator and know your course length (commonly 10–30 days) and daily capsule count.

▪Get a workup first: low testosterone or infertility should be evaluated medically before self-experimenting with any supplement.

▪Have water ready: capsules are usually taken 15–20 minutes before a meal with water.

How To Take

▪Swallow whole: take the capsule(s) with water, before a meal, once daily unless a specific product directs otherwise.

▪Keep to the course: take it consistently for the course length, then stop — the convention is a short course, not continuous use.

▪Do not over-stack: avoid combining many organ bioregulators; there is no controlled evidence for combinations.

After Dosing

▪Take the gap: after a course, leave the conventional multi-month interval before repeating.

▪Keep medical care first: pursue a proper evaluation for any fertility or testosterone concern rather than relying on a supplement.

▪Store it properly: reseal and keep capsules cool, dry and out of light.

Recommended Source

For high-purity Testoluten (20 mg oral), we point researchers to Prime Lab Peptides.

Why Prime Lab Peptides?

▪Top-rated on Trustpilot: Independently reviewed as the highest-rated peptide lab on Trustpilot — making it the best current source in the USA.

▪Third-party tested: Every batch ships with a Certificate of Analysis (COA) confirming purity and composition.

▪Consistent quality: ISO-aligned manufacturing and handling keep product integrity reliable batch to batch.

▪Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain.

▪Research-grade purity: Fit for educational and research use that demands high-quality peptides.

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

References

View Source ↗

How to take Testoluten

1Confirm the capsule strength and your target dose from the schedule on this page (each capsule is a fixed strength).

2Take the required number of Testoluten capsules by mouth once daily, swallowed whole with water, with or without food.

3Keep the daily dose consistent and follow any documented gradual 4-week escalation steps.

4Store the capsules sealed at room temperature, dry and away from light — no mixing or refrigeration needed.

Testoluten — frequently asked questions

Testoluten is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide.

No. Because Testoluten is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth.

Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number.

Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required.

The main practical difference is the route of administration: Testoluten is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page.

No. Research-grade Testoluten is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.

Written by Dr. Aimen Arij, PharmD

Related Bioregulators protocols

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Pemvidutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Pemvidutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

02Teduglutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Teduglutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

03Humanin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Humanin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

04P21 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. P21 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

05VK2735 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. VK2735 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

Research context

Read sources and limitations before applying a claim.

Safety and Tolerability in the Research Setting

Safety and efficacy are separate questions, and it is entirely possible for a compound to be well tolerated while remaining unproven for the condition of interest. That is the current situation for NAD+ precursors in Parkinson’s disease. The short-term tolerability data, particularly for oral nicotinamide riboside, are reassuring within the limits of the trials conducted, but they are not a statement about long-term safety, about frail or elderly populations over years, or about drug interactions in people taking multiple Parkinson’s medications. The most directly relevant safety dataset is NR-SAFE, which was explicitly designed to probe tolerability at a high dose. Over four weeks, 3,000 mg of NR daily produced only mild adverse events, with no moderate or severe events and no significant excess over placebo; the most frequently reported events in the NR arm included extrapyramidal symptoms, headache, tremor, muscle cramps, fatigue, nausea, and dyspepsia, several of which overlap with the underlying disease and its treatment.2 The absence of painful flushing is notable because flushing is a classic dose-limiting effect of nicotinic acid (niacin); NR and nicotinamide generally avoid the flushing that niacin causes, which is one reason they are favored for chronic dosing. The lower-dose NADPARK trial similarly reported that 1,000 mg daily was well tolerated over 30 days.1 Broader supplement-safety literature on NR in non-Parkinson populations has generally supported tolerability at commonly studied doses, and NMN has likewise been reported to raise blood NAD+ safely in short studies of healthy adults.13 These reassurances come with substantial caveats that a careful reader should hold in mind. First, the trials are small and short. Twenty participants over four weeks, or thirty over one month, cannot detect uncommon adverse events or effects that only emerge with months to years of exposure, which is exactly the exposure that disease modification would require. Second, the populations were selected: early-stage, often newly diagnosed patients able to participate in a trial, not the full spectrum of advanced disease, multimorbidity, and polypharmacy seen in practice. Third, theoretical concerns exist that have not been resolved in humans. Because NAD+ metabolism intersects with cell proliferation and with the kynurenine pathway, and because some preclinical work has raised tissue-specific concerns about chronic high-dose precursor exposure (for example, questions about metabolite accumulation with sustained oral NMN in animal models), long-term safety cannot be assumed from short-term tolerability.13 Fourth, methylation load is a plausible consideration: clearance of excess nicotinamide consumes methyl groups, and the metabolic consequences of chronically high precursor intake over years are not well characterized in this population. There is also the matter of source and quality. In a research context, the identity, purity, and endotoxin status of a compound materially affect both the validity of an experiment and the safety of any handling. Injectable NAD+ preparations used outside regulated trials vary widely in provenance, and intravenous NAD+ administration in particular has been associated with infusion-related discomfort (nausea, chest tightness, flushing) that is typically managed by slowing the infusion rate but underscores that route and formulation matter.4 None of this constitutes clinical guidance. The appropriate summary is that oral NR appears well tolerated in the short term at the doses tested in early Parkinson’s trials, that other precursors and routes have thinner safety records, and that long-term safety in Parkinson’s disease specifically remains unestablished pending completed, published, adequately long trials.

Source: dosagepeptide.com ↗

Where the Human Evidence Stands — and Why It Does Not Reach Lipogenesis

AOD-9604’s clinical record lives almost entirely in obesity, and understanding it is the fairest way to gauge whether any of the preclinical antilipogenic promise translated to people. The short version: it was tested seriously, in humans, at scale, and it did not deliver on its primary endpoint — and none of the human work measured lipogenesis at all. Across development, AOD-9604 was studied in roughly six human clinical trials enrolling more than 900 participants in total, a tally that derives from the sponsor’s development-program summary rather than a single publication.10 The centerpiece early study, a 12-week Phase 2 evaluation in obese adults (METAOD005) using once-daily oral dosing across several dose arms, was encouraging: the 1 mg arm reportedly lost more weight than placebo, and the results generated optimistic press.10 But the pivotal, longer, more rigorously controlled 24-week study (METAOD006) — a randomized, double-blind, placebo-controlled, multicenter trial that is the single published RCT on the compound — found that the weight-loss difference between AOD-9604 and placebo did not reach statistical significance at the primary endpoint, especially against a background of intensive diet and exercise.10 Development as an obesity drug was terminated in 2007. Two points matter for the antilipogenic question. First, every human study used weight and body-composition endpoints, plus safety and pharmacokinetic measures. None used the tools that actually quantify de novo lipogenesis in people — stable-isotope tracers (for example, deuterated water incorporation into palmitate), adipose or hepatic lipogenic-gene expression, or measured lipogenic flux. So even the human trials that exist are silent on whether AOD-9604 reduces fat synthesis; they measured the downstream outcome (weight), not the mechanism (lipogenesis), and the downstream outcome was not robustly positive. Second, the reassuring endocrine profile held up: the compound was reported not to raise IGF-1 and not to impair glucose tolerance, consistent with the “GH activity modulation” design.1 Trials ~6 studies, >900 participants total10 Pivotal design 24-week randomized, double-blind, placebo-controlled, multicenter (METAOD006); oral10 Primary endpoint Weight difference vs placebo did NOT reach statistical significance10 Lipogenesis measured? No — no DNL tracer, lipogenic-gene, or flux endpoints in any human study Endocrine profile No reported IGF-1 rise; no impaired glucose tolerance1 Outcome Obesity development halted in 200710 The honest reading is stark: the compound’s best-evidenced outcome (fat loss in obesity) was itself not robustly demonstrated in humans, and its proposed mechanism (reduced lipogenesis) was never measured in humans at all. Extrapolating from “inhibited ACC in rat fat pads” to “reduces lipogenesis in people” is a leap across species, tissues, and measurement methods, with no human data on the far side. For a measured look at how the clinical results are often characterized, see the site’s summary of what clinical trials indicate about the fat-burning potential of AOD-9604.

Source: dosagepeptide.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern: mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg. mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg. The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Source: dosagepeptide.com ↗

Dosage reference

Cortagen (20mg Vial) Dosage Protocol

Khavinson brain-cortex short-peptide bioregulator (AEDP) — research-only; not approved, benefits unproven.

Source: dosagepeptide.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Testoluten (Testes Bioregulator) Dosage Protocol

Quickstart Highlights

Supplies Needed

Protocol Overview

Dosing Protocol

Why Testoluten draws research interest

The fertility data are testilin’s, and they are in animals

A testicular-tissue extract has no fixed formula

Low testosterone and infertility need a workup, not a capsule

Oral Dosing Guide

Standard / Gradual Approach

Storage Instructions

Important Notes

How This Works

Lifestyle Factors

Potential Benefits & Side Effects

Reported Effects

Common Side Effects

Oral Administration

Before You Dose

How To Take

After Dosing

Recommended Source

Why Prime Lab Peptides?

References

How to take Testoluten

Testoluten — frequently asked questions

New protocols & dosing updates

Related Bioregulators protocols

Related questions

Safety and Tolerability in the Research Setting

Where the Human Evidence Stands — and Why It Does Not Reach Lipogenesis

How to convert mcg to mg (and back)

Cortagen (20mg Vial) Dosage Protocol

Peptide Therapy Guide Editorial Team

Triptorelin Acetate Dosage Protocol - Peptide Dosages

Ventfort Vascular Bioregulator Protocol - Peptide Dosages

Thymulin Dosage Protocol - Peptide Dosages

Teriparatide Dosage Protocol - Peptide Dosages